Market Overview

Meda Board Issues Statement Confirming Contact by Mylan, Rejection of Proposal

Share:
Related MYL
Watch These 7 Huge Call Purchases In Friday Trade
Mylan And Biocon Says EMA Accept Its Regulatory Submission Of Biosimilar Pegfilgrastim
FTC blesses Mylan's takeover of Swedish pharma firm Meda AB (Seeking Alpha)

This statement is made by the Board of Directors (the ”Board”) of Meda AB pursuant to the Securities Markets Act and/or the Financial Instruments Trading act.

The Board hereby confirms that it has been contacted by Mylan, Inc. (NYSE: MYL) regarding an indicative proposal to combine the two businesses. The Board has convened and has decided to reject the proposal. All continued discussions between Meda and Mylan have been terminated without further actions.

The Board of Directors

Posted-In: News M&A

 

Related Articles (MYL)

View Comments and Join the Discussion!